Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses

Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response

(2009) Fatoumata B. Sow et al.   DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY

Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs

(2009) Alicia Olivier et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Nasopharyngeal aspirate cytokine levels 1 yr after severe respiratory syncytial virus infection

(2009) Maria Pino et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Developmental Regulation of NO-Mediated VEGF-Induced Effects in the Lung

(2008) Vineet Bhandari et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Innate immune response to viral infection of the lungs

(2008) Hayley See et al.   Paediatric Respiratory Reviews

Biomedical applications of sheep models: from asthma to vaccines

(2008) Jean-Pierre Y. Scheerlinck et al.   TRENDS IN BIOTECHNOLOGY